- Home
- CNOB vs NKTR Comparison
CNOB vs NKTR Comparison
Compare CNOB & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNOB
- NKTR
- Stock Information
- Founded
- CNOB 1982
- NKTR 1990
- Country
- CNOB United States
- NKTR United States
- Employees
- CNOB N/A
- NKTR N/A
- Industry
- CNOB Major Banks
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- CNOB Finance
- NKTR Health Care
- Exchange
- CNOB Nasdaq
- NKTR Nasdaq
- Market Cap
- CNOB 1.3B
- NKTR 1.2B
- IPO Year
- CNOB 1996
- NKTR 1994
- Fundamental
- Price
- CNOB $24.42
- NKTR $60.13
- Analyst Decision
- CNOB Buy
- NKTR Strong Buy
- Analyst Count
- CNOB 1
- NKTR 6
- Target Price
- CNOB $31.00
- NKTR $91.67
- AVG Volume (30 Days)
- CNOB 274.5K
- NKTR 964.6K
- Earning Date
- CNOB 10-30-2025
- NKTR 11-06-2025
- Dividend Yield
- CNOB 2.97%
- NKTR N/A
- EPS Growth
- CNOB N/A
- NKTR N/A
- EPS
- CNOB 0.80
- NKTR N/A
- Revenue
- CNOB $241,854,000.00
- NKTR $74,934,000.00
- Revenue This Year
- CNOB $50.62
- NKTR N/A
- Revenue Next Year
- CNOB $28.54
- NKTR N/A
- P/E Ratio
- CNOB $30.44
- NKTR N/A
- Revenue Growth
- CNOB N/A
- NKTR N/A
- 52 Week Low
- CNOB $20.61
- NKTR $6.48
- 52 Week High
- CNOB $29.31
- NKTR $63.92
- Technical
- Relative Strength Index (RSI)
- CNOB 46.54
- NKTR 60.52
- Support Level
- CNOB $23.25
- NKTR $53.73
- Resistance Level
- CNOB $24.79
- NKTR $63.92
- Average True Range (ATR)
- CNOB 0.83
- NKTR 4.20
- MACD
- CNOB -0.17
- NKTR -0.66
- Stochastic Oscillator
- CNOB 36.00
- NKTR 65.53
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.